{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:51:53Z","timestamp":1793386313689,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11916-023-01123-4","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T12:02:16Z","timestamp":1688040136000},"page":"461-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Episodic Migraine and Psychiatric Comorbidity: A Narrative Review of the Literature"],"prefix":"10.1007","volume":"27","author":[{"given":"Alexis","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia T.","family":"Minen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"1123_CR1","doi-asserted-by":"publisher","unstructured":"Stovner\u00a0LJ, et al. \u201cThe global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates,\u201d J. Headache Pain.\u00a02022;23(1):34\u2013022\u201301402\u20132.\u00a0https:\/\/doi.org\/10.1186\/s10194-022-01402-2.","DOI":"10.1186\/s10194-022-01402-2"},{"issue":"4","key":"1123_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"R Burch","year":"2018","unstructured":"Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496\u2013505. https:\/\/doi.org\/10.1111\/head.13281.","journal-title":"Headache"},{"key":"1123_CR3","unstructured":"The International Classification of Headache Disorders 3rd edition. Available: https:\/\/ichd-3.org\/."},{"key":"1123_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/head.13966","author":"DC Buse","year":"2020","unstructured":"Buse DC, et al. Demographics, headache features, and comorbidity profiles in relation to headache frequency in people with migraine: results of the American migraine prevalence and prevention (AMPP) study. Headache. 2020. https:\/\/doi.org\/10.1111\/head.13966.","journal-title":"Headache"},{"key":"1123_CR5","doi-asserted-by":"publisher","unstructured":"Jedynak j, et al. \u201cShift from high-frequency to low-frequency episodic migraine in patients treated with galcanezumab: results from two global randomized clinical trials,\u201d J. Headache Pain.\u00a02021;22(1):48\u2013021\u201301222-w.\u00a0https:\/\/doi.org\/10.1186\/s10194-021-01222-w.","DOI":"10.1186\/s10194-021-01222-w"},{"key":"1123_CR6","doi-asserted-by":"publisher","unstructured":"Buse DC,\u00a0et al.\u00a0\u201cComorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study,\u201d J. Headache Pain. 2020;21(1):23\u2013020\u20131084-y.\u00a0https:\/\/doi.org\/10.1186\/s10194-020-1084-y.","DOI":"10.1186\/s10194-020-1084-y"},{"key":"1123_CR7","doi-asserted-by":"publisher","unstructured":"Lee S, et al.\u00a0\u201cDifferences in frontal lobe dysfunction in patients with episodic and chronic migraine.\u201d\u00a0J Clin Med.\u00a02021;10(13):2779.\u00a0https:\/\/doi.org\/10.3390\/jcm10132779.\u00a0","DOI":"10.3390\/jcm10132779"},{"key":"1123_CR8","doi-asserted-by":"crossref","unstructured":"Anonymous American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. (5th ed.) Arlington, VA: American Psychiatric Publishing, 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1123_CR9","doi-asserted-by":"publisher","unstructured":"Dresler T,\u00a0et al. \u201cUnderstanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications,\u201d J. Headache Pain.\u00a02019;20(1):51\u2013019\u20130988-x.\u00a0https:\/\/doi.org\/10.1186\/s10194-019-0988-x.","DOI":"10.1186\/s10194-019-0988-x"},{"key":"1123_CR10","doi-asserted-by":"publisher","unstructured":"Altamura C,\u00a0et al. \u201cPathophysiological bases of comorbidity in migraine,\u201d Front. Hum. Neurosci.\u00a02021;15:640574.\u00a0https:\/\/doi.org\/10.3389\/fnhum.2021.640574.","DOI":"10.3389\/fnhum.2021.640574"},{"issue":"11","key":"1123_CR11","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1093\/pm\/pnaa271","volume":"21","author":"A Planchuelo-G\u00f3mez","year":"2020","unstructured":"Planchuelo-G\u00f3mez A, et al. Gray matter structural alterations in chronic and episodic migraine: a morphometric magnetic resonance imaging study. Pain Med. 2020;21(11):2997\u20133011.","journal-title":"Pain Med"},{"key":"1123_CR12","doi-asserted-by":"publisher","unstructured":"Karimi L,\u00a0et al. \u201cThe migraine-anxiety comorbidity among migraineurs: a systematic review,\u201d Front. Neurol. 2021;11:613372.\u00a0https:\/\/doi.org\/10.3389\/fneur.2020.613372.","DOI":"10.3389\/fneur.2020.613372"},{"issue":"7","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/0333102414552532","volume":"35","author":"AM Adams","year":"2015","unstructured":"Adams AM, et al. The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) Study methods and baseline results. Cephalalgia. 2015;35(7):563\u201378. https:\/\/doi.org\/10.1177\/0333102414552532.","journal-title":"Cephalalgia"},{"issue":"3","key":"1123_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/head.13215","volume":"58","author":"H Chu","year":"2018","unstructured":"Chu H, et al. Associations between depression\/anxiety and headache frequency in migraineurs: a cross-sectional study. Headache. 2018;58(3):407\u201315. https:\/\/doi.org\/10.1111\/head.13215.","journal-title":"Headache"},{"key":"1123_CR15","doi-asserted-by":"publisher","unstructured":"Giannini\u00a0G, et al. \u201cCephalalgiaphobia as a feature of high-frequency migraine: a pilot study,\u201d J. Headache Pain. 2013;14(1):49\u20132377\u201314\u201349.\u00a0https:\/\/doi.org\/10.1186\/1129-2377-14-49.","DOI":"10.1186\/1129-2377-14-49"},{"key":"1123_CR16","doi-asserted-by":"publisher","unstructured":"Amiri P,\u00a0\u00a0et al. \u201cMigraine: a review on its history, global epidemiology, risk factors, and comorbidities,\u201d\u00a0Front.Neurol.\u00a02022;12:800605.\u00a0https:\/\/doi.org\/10.3389\/fneur.2021.800605.","DOI":"10.3389\/fneur.2021.800605"},{"issue":"6","key":"1123_CR17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1526-4610.2011.01907.x","volume":"51","author":"BL Peterlin","year":"2011","unstructured":"Peterlin BL, Nijjar SS, Tietjen GE. Post-traumatic stress disorder and migraine: epidemiology, sex differences, and potential mechanisms. Headache. 2011;51(6):860\u20138.","journal-title":"Headache"},{"key":"1123_CR18","doi-asserted-by":"publisher","unstructured":"Bainomugisa\u00a0 CK,\u00a0et al.\u00a0\u201cUsing monozygotic twins to dissect common genes in posttraumatic stress disorder and migraine,\u201d Front. Neurosci. 2021;15:678350.\u00a0https:\/\/doi.org\/10.3389\/fnins.2021.678350.","DOI":"10.3389\/fnins.2021.678350"},{"issue":"9","key":"1123_CR19","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.5664\/jcsm.9992","volume":"18","author":"O Rantanen","year":"2022","unstructured":"Rantanen O, Hollmen M, Bachour A. Migraine may disturb sleep perception during sleep onset: a retrospective data analysis. J Clin Sleep Med. 2022;18(9):2113\u20137. https:\/\/doi.org\/10.5664\/jcsm.9992.","journal-title":"J Clin Sleep Med"},{"issue":"5","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/head.14105","volume":"61","author":"A Vgontzas","year":"2021","unstructured":"Vgontzas A, et al. Baseline sleep quality, stress, and depressive symptoms, and subsequent headache occurrence in a six-week prospective cohort study of patients with episodic migraine. Headache. 2021;61(5):727\u201333.","journal-title":"Headache"},{"key":"1123_CR21","doi-asserted-by":"publisher","unstructured":"Klenofsky B. et al. \u201cEpisodic migraine comorbidities: avoiding pitfalls and taking therapeutic opportunities,\u201d Curr. Pain Headache Rep. 2019;23(1):1\u2013019\u20130742\u20138.\u00a0https:\/\/doi.org\/10.1007\/s11916-019-0742-8.","DOI":"10.1007\/s11916-019-0742-8"},{"issue":"5","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/head.14106","volume":"61","author":"J Yin","year":"2021","unstructured":"Yin J, et al. Prevalence and association of lifestyle and medical-, psychiatric-, and pain-related comorbidities in patients with migraine: a cross-sectional study. Headache. 2021;61(5):715\u201326.","journal-title":"Headache"},{"key":"1123_CR23","doi-asserted-by":"publisher","unstructured":"Tiseo C, et al.\u00a0\u201cMigraine and sleep disorders: a systematic review,\u201d J. Headache Pain. 2020;21(1):126\u2013020\u201301192\u20135.\u00a0https:\/\/doi.org\/10.1186\/s10194-020-01192-5.","DOI":"10.1186\/s10194-020-01192-5"},{"issue":"2","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","volume":"15","author":"T Sprenger","year":"2018","unstructured":"Sprenger T, Viana M, Tassorelli C. Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics. 2018;15(2):313\u201323. https:\/\/doi.org\/10.1007\/s13311-018-0621-8.","journal-title":"Neurotherapeutics"},{"issue":"10","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1177\/0333102418789072","volume":"38","author":"DC Buse","year":"2018","unstructured":"Buse DC, et al. Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab. Cephalalgia. 2018;38(10):1622\u201331. https:\/\/doi.org\/10.1177\/0333102418789072.","journal-title":"Cephalalgia"},{"issue":"7","key":"1123_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1177\/0333102413515348","volume":"34","author":"LJ Stovner","year":"2014","unstructured":"Stovner LJ, et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomized, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2014;34(7):523\u201332. https:\/\/doi.org\/10.1177\/0333102413515348.","journal-title":"Cephalalgia"},{"issue":"5","key":"1123_CR27","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","volume":"68","author":"AH Boal","year":"2016","unstructured":"Boal AH, et al. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension. 2016;68(5):1132\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08188.","journal-title":"Hypertension"},{"key":"1123_CR28","doi-asserted-by":"crossref","unstructured":"Silberstein SD,\u00a0et al.\u00a0\u201cEvidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society,\u201d Neurology. 2012;78(17):1337\u20131345.","DOI":"10.1212\/WNL.0b013e3182535d20"},{"key":"1123_CR29","doi-asserted-by":"publisher","unstructured":"Burch R. \u201cAntidepressants for preventive treatment of migraine,\u201d Curr. Treat. Options Neurol. 2019;21(4):18\u2013019\u20130557\u20132.\u00a0https:\/\/doi.org\/10.1007\/s11940-019-0557-2.","DOI":"10.1007\/s11940-019-0557-2"},{"key":"1123_CR30","doi-asserted-by":"crossref","unstructured":"Krymchantowski AV, da Cunha Jevoux C, Bigal ME. \u201cTopiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders,\u201d J Headache Pain.\u00a02011;13:53\u201359.","DOI":"10.1007\/s10194-011-0395-4"},{"issue":"4","key":"1123_CR31","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.ncl.2019.07.004","volume":"37","author":"SK Parikh","year":"2019","unstructured":"Parikh SK, Silberstein SD. Preventive treatment for episodic migraine. Neurol Clin. 2019;37(4):753\u201370. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.004.","journal-title":"Neurol Clin"},{"issue":"2","key":"1123_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1526-4610.2005.05029.x","volume":"45","author":"SN Ozyalcin","year":"2005","unstructured":"Ozyalcin SN, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache. 2005;45(2):144\u201352. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.05029.x.","journal-title":"Headache"},{"key":"1123_CR33","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.5144","author":"Y Orlova","year":"2018","unstructured":"Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurol. 2018. https:\/\/doi.org\/10.1001\/jamaneurol.2017.5144.","journal-title":"JAMA Neurol"},{"issue":"6","key":"1123_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/wnl.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754\u201362. https:\/\/doi.org\/10.1212\/wnl.55.6.754.","journal-title":"Neurology"},{"key":"1123_CR35","doi-asserted-by":"publisher","unstructured":"Holroyd KA, et al. \u201cEffect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial,\u201d Bmj. 2010;341: c4871.\u00a0https:\/\/doi.org\/10.1136\/bmj.c4871.","DOI":"10.1136\/bmj.c4871"},{"issue":"24","key":"1123_CR36","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1001\/jama.2013.282533","volume":"310","author":"SW Powers","year":"2013","unstructured":"Powers SW, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622\u201330. https:\/\/doi.org\/10.1001\/jama.2013.282533.","journal-title":"JAMA"},{"issue":"9","key":"1123_CR37","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/head.13657","volume":"59","author":"EK Seng","year":"2019","unstructured":"Seng EK, et al. Does mindfulness-based cognitive therapy for migraine reduce migraine-related disability in people with episodic and chronic migraine? A phase 2b pilot randomized clinical trial. Headache. 2019;59(9):1448\u201367. https:\/\/doi.org\/10.1111\/head.13657.","journal-title":"Headache"},{"issue":"Suppl 1","key":"1123_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10072-019-03802-w","volume":"40","author":"L Grazzi","year":"2019","unstructured":"Grazzi L, et al. ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study. Neurol Sci. 2019;40(Suppl 1):191\u20132. https:\/\/doi.org\/10.1007\/s10072-019-03802-w.","journal-title":"Neurol Sci"},{"issue":"3","key":"1123_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/j.pain.0000000000002372","volume":"163","author":"SAB Burrowes","year":"2022","unstructured":"Burrowes SAB, et al. Enhanced mindfulness-based stress reduction in episodic migraine-effects on sleep quality, anxiety, stress, and depression: a secondary analysis of a randomized clinical trial. Pain. 2022;163(3):436\u201344. https:\/\/doi.org\/10.1097\/j.pain.0000000000002372.","journal-title":"Pain"},{"issue":"8","key":"1123_CR40","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/j.pain.0000000000001860","volume":"161","author":"DA Seminowicz","year":"2020","unstructured":"Seminowicz DA, et al. Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes. Pain. 2020;161(8):1837\u201346. https:\/\/doi.org\/10.1097\/j.pain.0000000000001860.","journal-title":"Pain"},{"key":"1123_CR41","unstructured":"Segal Z, Williams M, and Teasdale J. Mindfulness-based cognitive therapy for depression, first edition: a new approach to preventing relapse. (1st ed.) Guilford Publications, Inc. 2001."},{"issue":"3","key":"1123_CR42","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1212\/CPJ.0000000000000984","volume":"11","author":"EK Seng","year":"2021","unstructured":"Seng EK, et al. Response to mindfulness-based cognitive therapy differs between chronic and episodic migraine. Neurol Clin Pract. 2021;11(3):194\u2013205. https:\/\/doi.org\/10.1212\/CPJ.0000000000000984.","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"1123_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00845519","volume":"8","author":"J Kabat-Zinn","year":"1985","unstructured":"Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163\u201390. https:\/\/doi.org\/10.1007\/BF00845519.","journal-title":"J Behav Med"},{"key":"1123_CR44","volume-title":"Mindfulness-based stress reduction (MBSR) authorized curriculum guide","author":"J Kabat-Zinn","year":"2017","unstructured":"Kabat-Zinn J, et al. Mindfulness-based stress reduction (MBSR) authorized curriculum guide. University of Massachusetts Medical School: Center for Mindfulness in Medicine, Healthcare, and Society; 2017."},{"issue":"3","key":"1123_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1001\/jamainternmed.2020.7090","volume":"181","author":"RE Wells","year":"2021","unstructured":"Wells RE, et al. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181(3):317\u201328. https:\/\/doi.org\/10.1001\/jamainternmed.2020.7090.","journal-title":"JAMA Intern Med"},{"key":"1123_CR46","doi-asserted-by":"crossref","unstructured":"Spitzer RL, Kroenke K, Williams JBW. \u201cA brief measure for assessing generalized anxiety disorder: the GAD-7,\u201d Arch Intern Med. 2006;166(10):1092.","DOI":"10.1001\/archinte.166.10.1092"},{"key":"1123_CR47","doi-asserted-by":"crossref","unstructured":"Kroenke K, et al.\u00a0\u201cThe PHQ-8 as a measure of current depression in the general population,\u201dJ Affect Disord. 2009;114(1):163.","DOI":"10.1016\/j.jad.2008.06.026"},{"issue":"9","key":"1123_CR48","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"1123_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1073191111411667","volume":"18","author":"PA Pilkonis","year":"2011","unstructured":"Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS\u00ae): depression, anxiety, and anger. Assessment. 2011;18(3):263\u201383. https:\/\/doi.org\/10.1177\/1073191111411667.","journal-title":"Assessment."},{"key":"1123_CR50","unstructured":"Juang KD, et al.\u00a0\u201cUse of the hospital anxiety and depression scale as a screening tool for patients with headache.\u201d 1999;62(11):749\u2013755."},{"key":"1123_CR51","doi-asserted-by":"crossref","unstructured":"Beck AT, Steer RA, and Brown G.\u00a0 \u201cBeck depression inventory\u2013II (BDI-II),\u201d Apa Psyctests.\u00a01996.","DOI":"10.1037\/t00742-000"},{"issue":"5","key":"1123_CR52","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/1359105316684938","volume":"24","author":"SH Baik","year":"2019","unstructured":"Baik SH, et al. Reliability and validity of the perceived stress scale-10 in Hispanic Americans with English or Spanish language preference. J Health Psychol. 2019;24(5):628\u201339. https:\/\/doi.org\/10.1177\/1359105316684938.","journal-title":"J Health Psychol"},{"issue":"4","key":"1123_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1389-9457(00)00065-4","volume":"2","author":"CH Bastien","year":"2001","unstructured":"Bastien CH, Vallieres A, Morin CM. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297\u2013307. https:\/\/doi.org\/10.1016\/s1389-9457(00)00065-4.","journal-title":"Sleep Med"},{"issue":"4","key":"1123_CR54","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1037\/1040-3590.7.4.524","volume":"7","author":"MJL Sullivan","year":"1995","unstructured":"Sullivan MJL, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524\u201332.","journal-title":"Psychol Assess"},{"key":"1123_CR55","doi-asserted-by":"crossref","unstructured":"Simons JS, Gaher RM. \u201cDistress tolerance scale (DTS),\u201d Apa Psyctests, 2005.","DOI":"10.1037\/t13498-000"},{"issue":"8","key":"1123_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1526-4610.2000.040008647.x","volume":"40","author":"DJ French","year":"2000","unstructured":"French DJ, et al. Perceived self-efficacy and headache-related disability. Headache. 2000;40(8):647\u201356. https:\/\/doi.org\/10.1046\/j.1526-4610.2000.040008647.x.","journal-title":"Headache"},{"issue":"3","key":"1123_CR57","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/head.14031","volume":"61","author":"RM Speck","year":"2021","unstructured":"Speck RM, et al. Psychometric validation and meaningful within-patient change of the migraine-specific quality of life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine. Headache. 2021;61(3):511\u201326. https:\/\/doi.org\/10.1111\/head.14031.","journal-title":"Headache"},{"issue":"6 Suppl 1","key":"1123_CR58","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1212\/wnl.56.suppl_1.s20","volume":"56","author":"WF Stewart","year":"2001","unstructured":"Stewart WF, et al. Development and testing of the migraine disability assessment (MIDAS) questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20\u20138. https:\/\/doi.org\/10.1212\/wnl.56.suppl_1.s20.","journal-title":"Neurology"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01123-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01123-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T09:20:28Z","timestamp":1693214428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01123-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01123-4","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"29 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}